22 research outputs found
WS12.1 Evidence of diminished FEV1 in CF 6-year-olds followed in the European CF registry, 2007–2009
Get PDFWS24.5 Unresponsive patients benefit from switching intravenous antibiotic treatments for pulmonary exacerbation
Get PDF180 Choice of IV vs. non-IV antibiotics for treating pulmonary exacerbations in patients with cystic fibrosis
Get PDFSample size estimation for CF clinical trials using rate of lung function decline (RLFD) as an efficacy endpoint
Get PDFWS12.1 Evidence of diminished FEV1 in CF 6-year-olds followed in the European CF registry, 2007–2009
No full textSample size estimation for CF clinical trials using rate of lung function decline (RLFD) as an efficacy endpoint
No full text
WS7.6 Incorporation of a third inhaled antipseudomonal antibiotic class into the management of patients at an adult CF care center
No full textWS24.5 Unresponsive patients benefit from switching intravenous antibiotic treatments for pulmonary exacerbation
No full text337 Changing incidence and thresholds for pulmonary exacerbation treatment, North America 1995-2005
No full text
